BLPH Annual EBIT
-$22.38 M
-$2.22 M-11.03%
31 December 2022
Summary:
As of January 23, 2025, BLPH annual earnings before interest & taxes is -$22.38 million, with the most recent change of -$2.22 million (-11.03%) on December 31, 2022. During the last 3 years, it has fallen by -$4.91 million (-28.11%).BLPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLPH Quarterly EBIT
-$2.17 M
+$3.09 M+58.74%
30 September 2023
Summary:
As of January 23, 2025, BLPH quarterly earnings before interest & taxes is -$2.17 million, with the most recent change of +$3.09 million (+58.74%) on September 30, 2023. Over the past year, it has increased by +$2.95 million (+57.58%).BLPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLPH TTM EBIT
-$11.04 M
+$2.95 M+21.07%
30 September 2023
Summary:
As of January 23, 2025, BLPH TTM earnings before interest & taxes is -$11.04 million, with the most recent change of +$2.95 million (+21.07%) on September 30, 2023. Over the past year, it has increased by +$10.54 million (+48.85%).BLPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLPH EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.0% | +57.6% | +48.9% |
| 3 y3 years | -28.1% | +57.6% | +48.9% |
| 5 y5 years | +9.0% | +68.2% | +48.9% |
BLPH EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +30.7% | -246.7% | at high |
Bellerophon Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$2.17 M(-58.7%) | -$11.04 M(-21.1%) |
| June 2023 | - | -$5.26 M(-455.6%) | -$13.98 M(-8.4%) |
| Mar 2023 | - | $1.48 M(-129.1%) | -$15.26 M(-31.8%) |
| Dec 2022 | -$22.38 M(+11.0%) | -$5.08 M(-0.6%) | -$22.38 M(+3.8%) |
| Sept 2022 | - | -$5.12 M(-21.8%) | -$21.57 M(+1.5%) |
| June 2022 | - | -$6.54 M(+15.9%) | -$21.26 M(+6.6%) |
| Mar 2022 | - | -$5.64 M(+32.0%) | -$19.94 M(-1.1%) |
| Dec 2021 | -$20.16 M(-23.3%) | -$4.27 M(-11.0%) | -$20.16 M(-16.1%) |
| Sept 2021 | - | -$4.80 M(-8.1%) | -$24.03 M(-12.6%) |
| June 2021 | - | -$5.23 M(-10.8%) | -$27.49 M(-1.9%) |
| Mar 2021 | - | -$5.86 M(-28.1%) | -$28.02 M(+6.7%) |
| Dec 2020 | -$26.28 M(+50.4%) | -$8.15 M(-1.4%) | -$26.28 M(+17.1%) |
| Sept 2020 | - | -$8.26 M(+43.4%) | -$22.45 M(+19.5%) |
| June 2020 | - | -$5.76 M(+40.1%) | -$18.77 M(+8.9%) |
| Mar 2020 | - | -$4.11 M(-4.8%) | -$17.24 M(-1.3%) |
| Dec 2019 | -$17.47 M(-37.3%) | -$4.32 M(-6.0%) | -$17.47 M(-2.1%) |
| Sept 2019 | - | -$4.59 M(+8.7%) | -$17.84 M(-11.2%) |
| June 2019 | - | -$4.22 M(-2.7%) | -$20.08 M(-15.4%) |
| Mar 2019 | - | -$4.34 M(-7.3%) | -$23.73 M(-14.9%) |
| Dec 2018 | -$27.88 M | -$4.68 M(-31.4%) | -$27.88 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$6.83 M(-13.2%) | -$30.50 M(+2.2%) |
| June 2018 | - | -$7.87 M(-7.3%) | -$29.86 M(+5.5%) |
| Mar 2018 | - | -$8.49 M(+16.2%) | -$28.31 M(+15.1%) |
| Dec 2017 | -$24.60 M(+3.5%) | -$7.31 M(+18.2%) | -$24.60 M(+0.1%) |
| Sept 2017 | - | -$6.18 M(-2.2%) | -$24.58 M(+8.7%) |
| June 2017 | - | -$6.32 M(+32.2%) | -$22.61 M(+5.4%) |
| Mar 2017 | - | -$4.78 M(-34.4%) | -$21.45 M(-9.7%) |
| Dec 2016 | -$23.76 M(-50.7%) | -$7.29 M(+72.9%) | -$23.76 M(-13.1%) |
| Sept 2016 | - | -$4.22 M(-18.3%) | -$27.33 M(-20.3%) |
| June 2016 | - | -$5.16 M(-27.2%) | -$34.28 M(-15.8%) |
| Mar 2016 | - | -$7.09 M(-34.7%) | -$40.73 M(-12.5%) |
| Dec 2015 | -$48.23 M(-19.3%) | -$10.86 M(-2.7%) | -$46.57 M(-4.0%) |
| Sept 2015 | - | -$11.17 M(-3.8%) | -$48.49 M(-8.2%) |
| June 2015 | - | -$11.61 M(-10.2%) | -$52.82 M(-9.2%) |
| Mar 2015 | - | -$12.93 M(+1.1%) | -$58.17 M(-2.6%) |
| Dec 2014 | -$59.75 M(-3.6%) | -$12.79 M(-17.5%) | -$59.75 M(-6.3%) |
| Sept 2014 | - | -$15.49 M(-8.7%) | -$63.74 M(+32.1%) |
| June 2014 | - | -$16.96 M(+16.9%) | -$48.25 M(+54.2%) |
| Mar 2014 | - | -$14.51 M(-13.5%) | -$31.29 M(+86.5%) |
| Dec 2013 | -$62.00 M(+34.1%) | -$16.77 M | -$16.77 M |
| Dec 2012 | -$46.23 M | - | - |
FAQ
- What is Bellerophon Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual EBIT year-on-year change?
- What is Bellerophon Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly EBIT year-on-year change?
- What is Bellerophon Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics TTM EBIT year-on-year change?
What is Bellerophon Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BLPH is -$22.38 M
What is the all time high annual EBIT for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual earnings before interest & taxes is -$17.13 M
What is Bellerophon Therapeutics annual EBIT year-on-year change?
Over the past year, BLPH annual earnings before interest & taxes has changed by -$2.22 M (-11.03%)
What is Bellerophon Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BLPH is -$2.17 M
What is the all time high quarterly EBIT for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly earnings before interest & taxes is $1.48 M
What is Bellerophon Therapeutics quarterly EBIT year-on-year change?
Over the past year, BLPH quarterly earnings before interest & taxes has changed by +$2.95 M (+57.58%)
What is Bellerophon Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BLPH is -$11.04 M
What is the all time high TTM EBIT for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high TTM earnings before interest & taxes is -$11.04 M
What is Bellerophon Therapeutics TTM EBIT year-on-year change?
Over the past year, BLPH TTM earnings before interest & taxes has changed by +$10.54 M (+48.85%)